FILTRIX Logo FILTRIX Find Your Edge →
Ticker Report — Active Last signal ·

$CHRS

Trade-Ideas alerts 53.4% at 5-min n=58 2022-01-12 → 2026-08-18

⚠ SMALL SAMPLE · 58 alerts only. Statistics may have high variance — interpret with caution.

🏢 Company Profile

📍 NASDAQ 📅 IPO: Nov 06, 2014 🔗 www.coherus.com
💰 Market Cap: $179.2M 👥 Employees: 144
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its portfolio includes LOQTORZI which was developed for its ability to block PD-1 interactions with its ligands, PD-L1 and PD-L2, by binding to the FG loop on the PD-1 receptor. Company believe blocking PD-1 interactions with PD-L1 and PD-L2 can help to promote the immune systems.
Total alerts
58
Trade-Ideas signal history
Win rate · 5MIN
53.4%
Best timeframe baseline
Avg gain · 5MIN
-0.19%
Per-alert expectancy
Avg MFE
+6.56%
Max potential excursion

Practice trading CHRS on historical setups — browse all patterns across all tickers →

📈 Performance by Timeframe

5MIN

Win Rate: 53.4%
Avg Gain: -0.19%
Avg Winner: +2.09%
Avg Loser: -2.81%
Best: +5.61%
Worst: -7.01%
Trades: 31/27

15MIN

Win Rate: 39.7%
Avg Gain: -0.65%
Avg Winner: +3.38%
Avg Loser: -3.40%
Best: +13.64%
Worst: -8.61%
Trades: 23/34

30MIN

Win Rate: 41.4%
Avg Gain: -0.35%
Avg Winner: +4.00%
Avg Loser: -3.53%
Best: +13.58%
Worst: -13.67%
Trades: 24/33

60MIN

Win Rate: 50.0%
Avg Gain: -0.43%
Avg Winner: +4.31%
Avg Loser: -5.35%
Best: +15.66%
Worst: -17.41%
Trades: 29/28

EOD (End of Day)

Win Rate: 39.7%
Avg Gain: -1.64%
Avg Winner: +6.92%
Avg Loser: -7.48%
Best: +22.26%
Worst: -22.33%
Trades: 23/34

🚀 Max Favorable / Adverse Excursion (MFE/MAE)

Institutional-grade metrics showing the maximum profit potential and risk for each alert.

📈 MFE (Max Profit Potential)

Average MFE: +6.56%
Best MFE: +25.65%
Avg Time to MFE: 95 min

On average, CHRS alerts reach +6.56% profit potential within 95 minutes.

📉 MAE (Max Drawdown Risk)

Average MAE: -2.86%
Worst MAE: -17.76%
Avg Time to MAE: 8 min

Before reaching MFE, expect an average drawdown of 2.86%.

⚖️ Risk/Reward Ratio

2.3:1

Excellent risk/reward - potential gain is 2.3x the typical drawdown.

💡 Trading Insight: Based on 58 alerts, CHRS typically reaches +6.56% profit before pulling back. Consider setting profit targets around 5.2% to capture most of the move.

🌅 Premarket Gap Analysis (9:25 → 9:30)

Total Gaps Analyzed 58
Gap Up % 39.7%
Avg Gap -0.29%
Best Gap +2.36%

🏭 Sector Comparison: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

How CHRS compares to 144 other tickers in the same sector.

5-Min Gain
CHRS: -0.19% Sector: -0.29% +0.10%
EOD Gain
CHRS: -1.64% Sector: +750.04% -751.68%
Avg MFE
CHRS: +6.56% Sector: +6.58% -0.02%

📋 Last 20 Alerts

Historical CHRS alerts with performance metrics calculated from 1-minute price data. Each row shows the actual price movement at different timeframes after the alert.

Date Time Price 5min 15min 30min 60min EOD MFE MAE Gap Result
2026-08-18 09:25:00 $1.26 +0.08% -1.46% +0.16% +4.96% +6.44% +8.03% -3.09% +0.09% WIN
2026-05-12 09:25:00 $1.79 -3.91% -0.28% -4.19% -8.43% -4.47% +1.68% -6.70% -2.23% LOSS
2026-05-11 09:25:00 $1.86 +3.12% +1.61% +2.96% +6.45% +4.84% +13.17% +0.54% +1.61% WIN
2026-02-20 09:25:00 $1.71 +0.29% -1.46% -3.22% -1.46% -4.68% +1.76% +1.75% -0.58% WIN
2026-02-13 09:25:00 $1.7 +1.08% +0.01% -0.29% +0.01% -5.29% +5.59% -3.52% +0.01% WIN
2026-02-04 09:25:00 $2.34 +2.14% +0.00% +1.07% +1.07% -5.13% +3.42% -2.56% -2.56% WIN
2026-02-02 09:25:00 $2.11 +1.66% +1.90% +3.08% +2.84% +2.84% +9.48% +0.00% +1.18% WIN
2026-01-29 09:25:00 $2.26 -3.01% -3.98% -3.76% -3.54% +3.10% +5.75% -7.96% -3.19% LOSS
2026-01-28 09:25:00 $2.53 +0.59% -2.17% -1.84% -5.34% -12.45% +1.58% -0.79% -0.79% WIN
2026-01-27 09:25:00 $2.32 +1.72% -1.94% -3.45% -1.94% +8.19% +12.75% -6.47% -0.43% WIN
2026-01-23 09:25:00 $1.86 +2.69% +7.53% +6.18% +9.67% +10.75% +16.67% -2.69% +0.27% WIN
2025-01-24 09:26:17 $1.36 -1.84% -2.21% -1.10% +0.10% -8.82% +1.51% -3.67% -1.47% LOSS
2024-12-10 09:29:20 $1.72 -1.08% -1.74% -0.29% -2.03% -6.40% +0.00% -2.33% -1.16% LOSS
2024-12-09 09:28:29 $1.76 +0.56% +0.67% +1.99% +2.84% -3.41% +5.11% -3.41% +1.14% WIN
2024-12-06 09:28:16 $1.52 -1.32% +0.33% +2.96% +2.96% +11.84% +14.47% -4.61% -1.97% LOSS
2024-12-05 09:26:44 $1.8 -3.06% -3.06% -3.89% -5.83% -16.11% +0.00% +0.00% +0.00% LOSS
2024-12-04 09:27:18 $1.78 +5.61% +0.00% -0.28% +0.00% -3.93% +9.55% -4.78% +2.25% WIN
2024-12-03 09:25:53 $2.14 -7.01% -1.87% +9.81% -6.50% -20.09% +13.55% -17.76% -4.67% LOSS
2024-11-21 09:25:49 $1.07 +1.87% -3.93% -3.74% +0.92% +2.80% +9.35% -5.61% +0.00% WIN
2024-11-08 09:26:59 $0.82 +2.67% -2.57% -2.73% -2.40% -0.54% +4.94% +1.29% +1.29% WIN

Table Metrics Explained:

  • 5min/15min/30min/60min/EOD: Price change at each timeframe (calculated from real minute-by-minute data)
  • MFE: Maximum Favorable Excursion - highest profit potential reached during the day
  • MAE: Maximum Adverse Excursion - worst drawdown experienced before reaching MFE
  • Gap: Premarket price gap from 9:25 AM to 9:30 AM market open
  • Result: WIN if 5min change > 0%, LOSS otherwise

⚠ CHRS Shows Negative Expectancy

Despite a 53.4% win rate, CHRS has -0.19% average expectancy because losses outweigh wins. Use the app to find filters that improve win size or reduce loss size, making CHRS profitable.

🔧 Fix CHRS Risk / Reward →

Why Analyze CHRS with FILTRIX?

🛡️ Realistic Entry Simulation

We don't inflate stats. Our analysis tracks only the first alert of the day for CHRS. This simulates a true "Gap & Go" entry at pre-market hours (9:25-9:30 AM), avoiding the trap of chasing a stock that has already extended.

💰 Max Potential (MFE) Analysis

How much is left in the move? On winning days, CHRS historically offers an average upside of +6.56% intraday. Our data helps you distinguish between a quick scalp and a runner.

📊 CHRS Momentum Personality

With a baseline win rate of 53.4%, CHRS shows negative expectancy despite winning more often - average losses (-2.81%) outweigh average wins (+2.09%). This suggests the need for tighter stops or better entry timing.

⏱️ Optimized Exit Timing

⚠️ Caution Advised: CHRS shows negative expectancy across all tested intraday timeframes (Best: 5MIN at -0.19%). This suggests CHRS is prone to fading after the open, making it a potential candidate for short-selling or quick scalps only.